Coya Therapeutics, Inc. (COYA)

Coya Therapeutics, Inc. (COYA) scores 44 out of 100 on boothcheck's 11-model valuation framework. Verdict: Avoid The estimated fair value is $4.26, representing a 3% margin of safety. Quantitative score: 62/100. Qualitative score: 20/100.

Analysis includes bear, base, and bull fair value targets using DCF, Graham, regression, and 8 other valuation models.

View full COYA analysis on boothcheck